#ASH20 | Tapan Kadia et al Ph2 #CPX351 + #Venetoclax in patients with AML ash.confex.com/ash/2020/webpr… | #leusm Koichi Takahashi Naveen Pemmaraju, MD Naval Daver, M.D. Nitin Jain Guillermo Garcia-Manero #endcancer @LeukemiaMDA

calling wannabe #medcomms specialists. Join us Wednesday 11 November to learn about working life at digital MedComms agency, Brandcast Health with Rosária Alexandre and Stephanie Perkin and Yana Stewart and Jess Fox. Everyone welcome zoom.us/webinar/regist…

This study is for anyone who wants to know the impact of COVID or future vaccines and their immune system and are eligible for Promise Study or the PCROWD study. The impactstudy.org.

wannabe #medcomms specialists, I think you'll find the recording of today's webinar interesting. My thanks to Rosária Alexandre, Stephanie Perkin, Yana Stewart and Jess Fox for talking about their work at Brandcast Health, a digital medcomms agency. Enjoy youtu.be/W6LfljGoh_A

Please sign up. Patients who have MGUS or smoldering or people who are at risk (age40-75) with a family member with B cell cancer or Black or of African descent Promise Study #pcrowd #mmsm

#ASH20 Attendees: Subscribe to our MD Anderson News @LeukemiaMDA Insights Newsletter to stay informed on the latest #leukemia research and available treatments. Archived issues available: bit.ly/3kiWNKv #leusm #MedEd #MPN #ALL #CML #CMML #AML #MDS #BPDCN #CLL #CART

Naveen Pemmaraju, MD @LeukemiaMDA This is THE question in AML ! #ASH20 Mohamad Mohty

#ASH20 | Venetoclax w/Decitabine Versus Intensive Chemotherapy in AML : A Propensity Score Matched Analysis Stratified by Risk of Treatment‐related Mortality onlinelibrary.wiley.com/doi/10.1002/aj… Tapan Kadia Gautam Borthakur Guillermo Garcia-Manero Nicholas Short MD Koichi Takahashi Nitin Jain Naveen Pemmaraju, MD #leusm

Tomorrow @ 7 AM PT, we are kicking off #ASH20 with a fireside chat between @StepahnieLeeMD and Dr. Anthony Fauci on how #COVID19 has affected hematologic malignancies. #ASHCOVID Log in to the platform early to be ready! ow.ly/p99f50CDfj9

SEISMA Magazine Ashmolean Museum Brandcast Health I hadn't seen this animation - very nice and thank you Brandcast Health

Why should bread have all the fun, when there's Weetabix? Serving up Heinz Beanz on bix for breakfast with a twist. #ItHasToBeHeinz #HaveYouHadYourWeetabix

Brandcast health is choosing to challenge! ✊🙌 International women’s day is a day where we can reflect and spotlight the amazing women we have in our lives and work place. 👏🏻 We are here to shine light on the challenges women face and to celebrate each and every one of them 💙

This one should be fun! We've all launched something and THEN realised users can't use it! Our next free Webinar is 14 April and features Dan Buckland and Tom Evans from Brandcast Health. Join us >> User Experience (UX): The Missing Link in #MedComms? zoom.us/webinar/regist…

Looking forward to seeing you all in person!! Our first hybrid meeting after more that a year! Submit your abstracts for #IMW21!

#briefing #betterbriefsproject #medcomms

Twenty percent of individuals with diabetes will develop painful diabetic sensorimotor peripheral neuropathy (DSPN). Learn more about the management of DSPN here: ow.ly/m5gJ50JRhQ1 #JDN

#ASH2022 is approaching and our collaborative network will present 9 orals on myeloma translational research C. Ola Landgren, M.D. Sylvester Comprehensive Cancer Center. Grateful to our collaborators Gareth Morgan Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Maclachlan K. nizar jacques bahlis Moffitt Cancer Center Heidelberg University & many more #mmsm 1/10

Which one is which? George and Jesus exchanging names. We also exchanged science and ideas between myeloid and lymphoid malignancies #IBC23

(1/7) As part of a suite of #CPTAC papers published across #CellPress today, we introduce our study Cell, led by Yifat Geffen, on how #PanCancer analysis of post-translational modifications reveals shared patterns of protein regulation: sciencedirect.com/science/articl…

👉👉👉Delighted to kick-off our exciting MPN Workshop of The Carolina ‘24 with an amazing plenary session on #JAK2 and #CALR Past, Present, Future Directions - two tour de force speakers 📣 to start us with Ross Levine & Jyoti Nangalia !!! #MPNSM | Ruben A. Mesa, MD Naveen Pemmaraju, MD VJHemOnc